SCHEMBL31280356

SCHEMBL31280356

COC(=O)[C@H](CC(C)C)NP(=O)(N[C@@H](CC(C)C)C(=O)OC)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CES2 O00748 1/20 0.46
▸ CES1 P23141 1/20 0.46
▸ BCHE P06276 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ MAPT P10636 3/20 0.44
▸ TAS1R3 Q7RTX0 1/20 0.42
▸ TAS1R1 Q7RTX1 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20213117 0.96 ALDH1A1 (0.42) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL20213115 0.96 ALDH1A1 (0.42) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL17198688 0.91 CA1 (0.48) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL18089732 0.87 ALDH1A1 (0.47) ALDH1A1TP53SMN1; SMN2CA1CA2
SCHEMBL28706139 0.87 ALDH1A1 (0.47) ALDH1A1TP53SMN1; SMN2CA1CA2
SCHEMBL30583780 0.85 MEN1 (0.41) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL18266887 0.84 PTGS2 (0.44) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL23819198 0.84 ALDH1A1 (0.51) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL17601836 0.80 CA1 (0.47) ALDH1A1LMNACYP3A4MAPK1HSD17B10
SCHEMBL23818597 0.78 CA1 (0.52) ALDH1A1LMNACYP3A4MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303359-B1 NUCLEOTIDES FOR THE TREATMENT OF CANCER IDENIX PHARMACEUTICALS LLC (US) 2024-11-06 — — EP disclosed
Send feedback